Casey Woodring Analyst Performance

Analyst at JPMorgan Chase & Co.

Casey Woodring is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 8 publicly traded companies. Over the past year, Casey Woodring has issued 11 stock ratings, including buy, hold, and sell recommendations. While full access to Casey Woodring's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Casey Woodring's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 11 Last 0 Years
Buy Recommendations: 36.36% 4 Buy Ratings
Companies Covered: 8 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	36.4%	4 ratings
Hold	54.5%	6 ratings
Sell	9.1%	1 ratings

Out of 11 total stock ratings issued by Casey Woodring at JPMorgan Chase & Co., the majority (54.5%) have been Hold recommendations, followed by 36.4% Buy and 9.1% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NYSE	62.5% of companies on NYSE	5 companies
NASDAQ	37.5% of companies on NASDAQ	3 companies

Casey Woodring, an analyst at JPMorgan Chase & Co., currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 8 companies	100.0%

Casey Woodring of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 3 companies	37.5%
MED PRODUCTS 2 companies	25.0%
MEDICAL SERVICES 2 companies	25.0%
MED - BIOMED/GENE 1 company	12.5%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
A Agilent Technologies	10/9/2025	Boost Price Target	$140.81	$165.00	Overweight
MTD Mettler-Toledo International	10/9/2025	Boost Price Target	$1,328.52	$1,285.00	Neutral
WAT Waters	10/9/2025	Boost Price Target	$328.36	$325.00	Neutral
TMO Thermo Fisher Scientific	10/9/2025	Boost Price Target	$536.70	$650.00	Overweight
GH Guardant Health	9/25/2025	Boost Price Target	$57.67	$70.00	Overweight
CRL Charles River Laboratories International	8/7/2025	Boost Price Target	$150.12	$160.00	Neutral
ICLR Icon	4/29/2025	Downgrade	$145.00	$150.00	Neutral
QDEL QuidelOrtho	4/21/2025	Lower Price Target	$24.35	$25.00	Underweight
CRL Charles River Laboratories International	2/20/2025	Lower Price Target	$164.90	$165.00	Neutral
ICLR Icon	2/3/2025	Lower Price Target	$195.96	$265.00	Overweight
CRL Charles River Laboratories International	2/3/2025	Lower Price Target	$161.46	$175.00	Neutral

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.